Gossamer Bio (GOSS) Operating Margin (2022 - 2025)
Historic Operating Margin for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to 369.44%.
- Gossamer Bio's Operating Margin fell 116500.0% to 369.44% in Q3 2025 from the same period last year, while for Sep 2025 it was 802.08%, marking a year-over-year decrease of 7329400.0%. This contributed to the annual value of 66.06% for FY2024, which is N/A changed from last year.
- Gossamer Bio's Operating Margin amounted to 369.44% in Q3 2025, which was down 116500.0% from 337.41% recorded in Q2 2025.
- Gossamer Bio's Operating Margin's 5-year high stood at 1612.12% during Q3 2022, with a 5-year trough of 372.23% in Q1 2025.
- In the last 4 years, Gossamer Bio's Operating Margin had a median value of 247.08% in 2024 and averaged 593.99%.
- The largest annual percentage gain for Gossamer Bio's Operating Margin in the last 5 years was -116500bps (2025), contrasted with its biggest fall of -3917600bps (2025).
- Quarter analysis of 4 years shows Gossamer Bio's Operating Margin stood at 1572.37% in 2022, then dropped by -13bps to 1369.77% in 2023, then crashed by -82bps to 247.08% in 2024, then crashed by -250bps to 369.44% in 2025.
- Its last three reported values are 369.44% in Q3 2025, 337.41% for Q2 2025, and 372.23% during Q1 2025.